Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. Positive results for ruxolitinib in graft-versus-host disease
  2. Mundipharma demonstrates superiority of non-opioid Penthrox in relieving pain
  3. Pfizer’s JAK1 inhibitor performs well in atopic dermatitis
  4. From injections to pills: FDA approves first oral GLP-1 for type 2 diabetes
  5. Keytruda approved in China as a monotherapy for NSCLC

Latest Content

Keytruda approved in China as a monotherapy for NSCLC

Merck has announced that Keytruda has been approved by the Chinese National Medical Products Administration (NMPA) as a monotherapy for first-line treatment of local advanced or metastatic non-small cell lung cancer (NSCLC).

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Close
Close
Close

Go Top